To better understand the humanistic and economic burden of focal seizures in children 2-12 years old.
Methods:
We conducted a targeted literature review by searching MEDLINE for English-language publications reporting on children 2-12 years old with focal seizures published in the United States since 2008.
Results:
Thirty-five publications were included. Incidence of focal seizures was 23.2 to 47.1 per 100,000 children per year; prevalence was 2.0 per 1,000 children, and ranged from 1.6 - 2.6 per 1,000 in patients of any age. Life expectancy was 47.3-61.8 years among children 3-12 years old. Patients took several antiepileptic drugs and experienced frequent seizures, sleep disorders, mood disorders, migraine, and seizure-related injuries (eg, bone fractures, sprains, open wounds). Children with focal seizures scored below average on cognitive assessments and up to 42%, 16%, and 19% had depression, anxiety, and attention-deficit disorder, respectively. Patients of any age had about 10 outpatient visits (2 epilepsy-related), 2 inpatient visits (less than 1 epilepsy-related), and 24 procedures (1 epilepsy-related) per year. Medication adherence was low: only half of pediatric patients maintained ≥90% adherence over 6 months. Annual total health care costs among patients of any age ranged from $18,369 - 38,549; first-year total health care costs for children were $19,883.
Conclusions:
Incidence and prevalence of focal seizures is high and the humanistic and economic burdens are significant. Future studies focused exclusively on children with focal seizures are needed to more precisely describe the burden. We also suggest further research and implementation of methods to improve medication adherence as an approach to lessen burden on these young patients.
BergATShinnarSLevySRTestaFM. Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia. 1999;40(4):445–452.
3.
BanerjeePNFilippiDAllen HauserW. The descriptive epidemiology of epilepsy—a review. Epilepsy Res. 2009;85(1):31–45.
4.
RussSALarsonKHalfonN. A national profile of childhood epilepsy and seizure disorder. Pediatrics. 2012;129(2):256–264.
5.
ChongLJamiesonNJGillD, et al.Children’s experiences of epilepsy: a systematic review of qualitative studies. Pediatrics. 2016;138(3):e20160658.
6.
CamfieldPCamfieldC. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 2015;17(2):117–123.
7.
BegleyCEDurginTL. The direct cost of epilepsy in the United States: a systematic review of estimates. Epilepsia. 2015;56(9):1376–1387.
8.
SchefferIEBerkovicSCapovillaG, et al.ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–521.
9.
BergATBerkovicSFBrodieMJ, et al.Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676–685.
10.
JensenMPBrunklausADorrisL, et al.The humanistic and economic burden of Dravet syndrome on caregivers and families: implications for future research. Epilepsy Behav. 2017;70(pt A):104–109.
11.
GallopKWildDNixonAVerdianLCramerJA. Impact of Lennox-Gastaut Syndrome (LGS) on health-related quality of life (HRQL) of patients and caregivers: literature review. Seizure. 2009;18(8):554–558.
TeixeiraJSantosME. Language skills in children with benign childhood epilepsy with centrotemporal spikes: a systematic review. Epilepsy Behav. 2018;84:15–21.
15.
SmithABBajomoOPalDK. A meta-analysis of literacy and language in children with rolandic epilepsy. Dev Med Child Neurol. 2015;57(11):1019–1026.
16.
LiuXCarneyPRBussingRSegalRCottlerLBWintersteinAG. Stimulants do not increase the risk of seizure-related hospitalizations in children with epilepsy. J Child Adolesc Psychopharmacol. 2018;28(2):111–116.
17.
SchraegleWANussbaumNLTitusJB. Executive dysfunction and depression in pediatric temporal lobe epilepsy: the contribution of hippocampal sclerosis and psychosocial factors. J Int Neuropsychol Soc. 2018;24(6):606–616.
18.
SmithLSinghalNEl AchkarCM, et al.PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum. Epilepsia. 2018;59(3):679–689.
19.
SchraegleWATitusJB. The relationship of seizure focus with depression, anxiety, and health-related quality of life in children and adolescents with epilepsy. Epilepsy Behav. 2017;68:115–122.
20.
WhealyMWirrellEWong-KisielLNickelsKPayneET. Prevalence and risk factors of peri-ictal autonomic changes in children with temporal lobe seizures. Pediatr Neurol. 2017;67:36–39.
21.
FallahAWeilAGWangSLewisEBacaCBMathernGW. Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with tuberous sclerosis complex. Epilepsy Behav. 2016;63:79–88.
22.
LoveCEWebbeFKimGLeeKHWesterveldMSalinasCM. The role of executive functioning in quality of life in pediatric intractable epilepsy. Epilepsy Behav. 2016;64:37–43.
23.
MaulisovaAKormanBReyG, et al.Atypical language representation in children with intractable temporal lobe epilepsy. Epilepsy Behav. 2016;58:91–96.
24.
ModiACGuilfoyleSMMannKARauschJR. A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia. 2016;57(3):e69–e75.
25.
SchraegleWANussbaumNLStefanatosAK. List-learning and verbal memory profiles in childhood epilepsy syndromes. Epilepsy Behav. 2016;62:159–165.
26.
VeenstraALRileyJDBarrettLE, et al.The impact of bilingualism on working memory in pediatric epilepsy. Epilepsy Behav. 2016;55:6–10.
27.
HawleySRAblahEHesdorfferD, et al.Prevalence of pediatric epilepsy in low-income rural Midwestern counties. Epilepsy Behav. 2015;53:190–196.
28.
Pestana KnightEMSchiltzNKBakakiPMKoroukianSMLhatooSDKaiboriboonK. Increasing utilization of pediatric epilepsy surgery in the United States between 1997 and 2009. Epilepsia. 2015;56(3):375–381.
29.
RyanJLMcGradyMEGuilfoyleSMJungerKArnettADModiAC. Health care charges for youth with newly diagnosed epilepsy. Neurology. 2015;85(6):490–497.
30.
Sánchez FernándezIAnSLoddenkemperT. Pediatric refractory epilepsy: a decision analysis comparing medical versus surgical treatment. Epilepsia. 2015;56(2):263–272.
31.
VegaYHSmithACockerillH, et al.Risk factors for reading disability in families with rolandic epilepsy. Epilepsy Behav. 2015;53:174–179.
32.
AblahEHesdorfferDCLiuY, et al.Prevalence of epilepsy in rural Kansas. Epilepsy Res. 2014;108(4):792–801.
33.
ModiACRauschJRGlauserTA. Early pediatric antiepileptic drug nonadherence is related to lower long-term seizure freedom. Neurology. 2014;82(8):671–673.
34.
PeljtoALBarker-CummingsCVasoliVM, et al.Familial risk of epilepsy: a population-based study. Brain. 2014;137(3):795–805.
35.
ArringtonDKNgY-TTroesterMMKerriganJFChapmanKE. Utility and safety of prolonged video-EEG monitoring in a tertiary pediatric epilepsy monitoring unit. Epilepsy Behav. 2013;27(2):346–350.
36.
BergATNickelsKWirrellEC, et al.Mortality risks in new-onset childhood epilepsy. Pediatrics. 2013;132(1):124–131.
37.
ChongJHesdorfferDCThurmanDJ, et al.The prevalence of epilepsy along the Arizona–Mexico border. Epilepsy Res. 2013;105(1-2):206–215.
38.
JainSVHornPSSimakajornboonNGlauserTA. Obstructive sleep apnea and primary snoring in children with epilepsy. J Child Neurol. 2013;28(1):77–82.
39.
ModiACGuilfoyleSMRauschJ. Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. J Pediatr Psychol. 2013;38(6):605–616.
40.
MoseleyBDWirrellECWong-KisielLCNickelsK. Early onset epilepsy is associated with increased mortality: a population-based study. Epilepsy Res. 2013;105(3):410–414.
41.
SchiltzNKKoroukianSMLhatooSDKaiboriboonK. Temporal trends in pre-surgical evaluations and epilepsy surgery in the U.S. from 1998 to 2009. Epilepsy Res. 2013;103(2-3):270–278.
42.
ChenS-YWuNBoulangerLSaccoP. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States. J Med Econ. 2013;16(2):240–248.
43.
KelleySAHartmanALKossoffEH. Comorbidity of migraine in children presenting with epilepsy to a tertiary care center. Neurology. 2012;79(5):468–473.
44.
MohammedHSKaufmanCBLimbrickDD, et al.Impact of epilepsy surgery on seizure control and quality of life: a 26-year follow-up study. Epilepsia. 2012;53(4):712–720.
45.
WirrellEWong-KisielLMandrekarJNickelsK. Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: a retrospective, population-based study: Predicting Intractability in Young Children. Epilepsia. 2012;53(9):1563–1569.
46.
ModiACRauschJRGlauserTA. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA. 2011;305(16):1669–1676.
47.
WirrellECGrossardtBRWong-KisielLCLNickelsKC. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res. 2011;95(1-2):110–118.
48.
KurthTLewisBEWalkerAM. Health care resource utilization in patients with active epilepsy: Health care Resource Utilization. Epilepsia. 2010;51(5):874–882.
49.
RoederRRoederKAsanoEChuganiHT. Depression and mental health help-seeking behaviors in a predominantly African American population of children and adolescents with epilepsy. Epilepsia. 2009;50(8):1943–1952.
50.
JainSVSimakajornboonSShapiroSMMortonLDLeszczyszynDJSimakajornboonN. Obstructive sleep apnea in children with epilepsy: prospective pilot trial: Obstructive sleep apnea and epilepsy in children. Acta Neurologica Scandinavica. 2012;125(1):e3–e6.
51.
SabazMCairnsDRLawsonJANheuNBleaselAFByeAM. Validation of a new quality of life measure for children with epilepsy. Epilepsia. 2000;41(6):765–774.
52.
MenkeAOrchardTJImperatoreGBullardKMMayer-DavisECowieCC. The prevalence of type 1 diabetes in the United States. Epidemiology. 2013;24(5):773–774.
53.
MaennerMJBlumbergSJKoganMDChristensenDYeargin-AllsoppMSchieveLA. Prevalence of cerebral palsy and intellectual disability among children identified in two U.S. National Surveys, 2011-2013. Ann Epidemiol. 2016;26(3):222–226.
FaughtREWeinerJRGuérinACunningtonMCDuhMS. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia. 2009;50(3):501–509.
56.
CramerJAWangZJChangE, et al.Healthcare utilization and costs in adults with stable and uncontrolled epilepsy. Epilepsy Behav. 2014;1:356–361.
57.
Al-AqeelSGershuniOAl-SabhanJHiligsmannM. Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. Cochrane Database Syst Rev. 2017;2:CD008312.
58.
SmithML. Neuropsychology in epilepsy: children are not small adults. Epilepsia. 2010;51(suppl 1):68–69.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
